Publications

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Authors: GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, KS Smith, DC ...

E-pub date: 1 Jun 2018

Journal name: Lancet Oncol

THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

Authors: GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, K Smith, DC B...

E-pub date: 1 Jun 2018

Journal name: NEURO-ONCOLOGY

11 The heterogeneous genomic and immune landscapes of lethal metastatic breast cancer

Authors: L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, E Greenstein, OM...

E-pub date: 1 Jun 2018

Journal name: ESMO Open

PO-329 Rejecting neutral tumour evolution across human cancer types

Authors: M Tarabichi, I Martincorena, M Gerstung, F Markowetz, P Spellman, Q Morris,...

E-pub date: 1 Jun 2018

Journal name: ESMO Open

Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo.

Authors: O Sonzogni, J Haynes, LA Seifried, YM Kamel, K Huang, MD BeGora, FA Yeung, ...

E-pub date: 1 Jun 2018

Journal name: PLoS Biol

Corrigendum to “GoldCLIP: Gel-omitted Ligation-dependent CLIP” [Genomics Proteomics Bioinformatics 16 (2) (2018) 136-143].

Authors: J Gu, M Wang, Y Yang, D Qiu, Y Zhang, J Ma, Y Zhou, GJ Hannon, Y Yu

E-pub date: 1 Jun 2018

Journal name: Genomics Proteomics Bioinformatics

PO-489 TP53 mutations and focal genomic amplifications for ctDNA detection in high-grade serous ovarian carcinoma

Authors: T Goranova, G Macintyre, D De Silva, D Ennis, I McNeish, J Brenton

E-pub date: 1 Jun 2018

Journal name: ESMO Open

PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer

Authors: E Moore, D Chandrananda, A Piskorz, F Mouliere, T Goranova, H Addley, R Cra...

E-pub date: 1 Jun 2018

Journal name: ESMO Open

Filters

Research Groups

Core Facilities

Start date

End date

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

11 The heterogeneous genomic and immune landscapes of lethal metastatic breast cancer

PO-329 Rejecting neutral tumour evolution across human cancer types

Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo.

Corrigendum to “GoldCLIP: Gel-omitted Ligation-dependent CLIP” [Genomics Proteomics Bioinformatics 16 (2) (2018) 136-143].

PO-489 TP53 mutations and focal genomic amplifications for ctDNA detection in high-grade serous ovarian carcinoma

PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (IMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

11 The heterogeneous genomic and immune landscapes of lethal metastatic breast cancer

PO-329 Rejecting neutral tumour evolution across human cancer types

Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo.

Corrigendum to “GoldCLIP: Gel-omitted Ligation-dependent CLIP” [Genomics Proteomics Bioinformatics 16 (2) (2018) 136-143].

PO-489 TP53 mutations and focal genomic amplifications for ctDNA detection in high-grade serous ovarian carcinoma

PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer